type here...

CATEGORIES

Medication

LATEST

1234Page 1 of 4

TRENDING

EDITORS CHOICE

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

The Trauma of Witnessing Charlie Kirk’s Murder and PTSD

Pat Farrell PhD -
The psychological effects of public space shootings extend beyond physical harm because they create a broad psychological impact on everyone present at the scene....

SUICIDE: IS AI RESPONSIBLE?

Christi Taylor-Jones -
The Raines discovered their son Adam in the closet where he hung himself with the support of a character on ChatGPT with whom he’d...

Depression isn’t Caused by Low Serotonin Level, Are SSRIs still Effective?

Isabella Soerjanto MD -
Several previous studies have concluded that SSRIs can significantly reduce the risk of depression. However, a recent study refutes this.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories